D. Roychowdhury

2.8k total citations · 1 hit paper
17 papers, 2.1k citations indexed

About

D. Roychowdhury is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, D. Roychowdhury has authored 17 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in D. Roychowdhury's work include Bladder and Urothelial Cancer Treatments (3 papers), Cancer Treatment and Pharmacology (3 papers) and Lung Cancer Treatments and Mutations (3 papers). D. Roychowdhury is often cited by papers focused on Bladder and Urothelial Cancer Treatments (3 papers), Cancer Treatment and Pharmacology (3 papers) and Lung Cancer Treatments and Mutations (3 papers). D. Roychowdhury collaborates with scholars based in United States, India and Denmark. D. Roychowdhury's co-authors include T. Oliver, Peter Albers, Malcolm J. Moore, Pierre Kerbrat, Peter Wersäll, I. Bodrogi, Alexander Knuth, Christian Lippert, Luigi Dogliotti and Steen Werner Hansen and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neurochemistry and Annals of Oncology.

In The Last Decade

D. Roychowdhury

17 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

2000 1.7k citations Hans von der Maase, Steen Werner Hansen et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by D. Roychowdhury

Since Specialization

Citations

This map shows the geographic impact of D. Roychowdhury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Roychowdhury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Roychowdhury more than expected).

Fields of papers citing papers by D. Roychowdhury

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Roychowdhury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Roychowdhury. The network helps show where D. Roychowdhury may publish in the future.

Co-authorship network of co-authors of D. Roychowdhury

This figure shows the co-authorship network connecting the top 25 collaborators of D. Roychowdhury. A scholar is included among the top collaborators of D. Roychowdhury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Roychowdhury. D. Roychowdhury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study 2023 ·Journal of Clinical Oncology ·Hans von der Maase, Steen Werner Hansen, J.T. Roberts, Luigi Dogliotti, T. Oliver, Malcolm J. Moore, I. Bodrogi, Peter Albers, Alexander Knuth, Christian Lippert, Pierre Kerbrat, Pedro Sánchez‐Rovira, Peter Wersäll, Simon Cleall, D. Roychowdhury, (unknown), Carla Visseren‐Grul, Pierfranco Conté	19
2	Effect of Prostaglandins A-1, E-2 and F-2a on Blood Plasma Levels of Testosterone, LH and FSH in Male Rats 2009 ·Andrologia ·(unknown), Anagha Gurjar, Urmila M. Joshi, A. R. Sheth, D. Roychowdhury	9
3	Effects of Prostaglandins E-1, E-2, F-1a and F-2a on Human Sperm Motility 2009 ·Andrologia ·(unknown), D. Roychowdhury	5
4	Preoperative treatment with pazopanib (GW786034), a multikinase angiogenesis inhibitor in early-stage non-small cell lung cancer (NSCLC): A proof-of-concept phase II study 2008 ·Journal of Clinical Oncology ·Nasser K. Altorki, Michael J. Guarino, (unknown), Harvey I. Pass, (unknown), (unknown), D. Roychowdhury, Tal Zaks, Lone H. Ottesen, David Yankelevitz	28
5	Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer 2006 ·International Journal of Gynecological Cancer ·(unknown), Timothy Perren, (unknown), Mona Ridderheim, James A. Cook, (unknown), D. Roychowdhury	9
6	Results of an analysis of cardiac function in 2,812 patients treated with lapatinib 2006 ·Journal of Clinical Oncology ·EA Perez, Julie Byrne, Isaac W. Hammond, (unknown), (unknown), Marvin Berger, Tal Zaks, Cristina Oliva, D. Roychowdhury, Steven H. Stein	31
7	First-line gemcitabine versus epirubicin in postmenopausal women aged 60 or older with metastatic breast cancer: a multicenter, randomized, phase III study 2005 ·Annals of Oncology ·Olavo Feher, P Vodvářka, Jacek Jassem, G Morack, Suresh H. Advani, K. Khoo, Dinesh Chandra Doval, (unknown), D. Roychowdhury, Michael A. Miller, Gϋnter von Minckwitz	66
8	Health-Related Quality-of-Life Parameters as Independent Prognostic Factors in Advanced or Metastatic Bladder Cancer 2003 ·Journal of Clinical Oncology ·D. Roychowdhury, (unknown), Astra M. Liepa	100
9	Antisense therapy directed to protein kinase C-alpha (affinitak, LY900003/ISIS 3521): Potential role in breast cancer 2003 ·Seminars in Oncology ·D. Roychowdhury, (unknown)	32
10	Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study breakdown → 2000 ·Journal of Clinical Oncology ·Hans von der Maase, Steen Werner Hansen, J.T. Roberts, Luigi Dogliotti, T. Oliver, Malcolm J. Moore, I. Bodrogi, Peter Albers, Alexander Knuth, Christian Lippert, Pierre Kerbrat, Pedro Sánchez‐Rovira, Peter Wersäll, Simon Cleall, D. Roychowdhury, (unknown), Carla Visseren‐Grul, Pierfranco Conté	1678
11	Paclitaxel (3-hour infusion) followed by carboplatin (24 hours after paclitaxel): a phase II study in advanced non-small cell lung cancer. 1997 ·PubMed ·D. Roychowdhury, Pinkal Desai, Yaowei Zhu	10
12	Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin. 1995 ·PubMed ·D. Roychowdhury, Claudia Linker	24
13	Effect of diabetes mellitus on activities of some glycolytic, hexose monophosphate & other enzymes of erythrocytes of different ages. 1982 ·PubMed ·(unknown), D. Roychowdhury	1
14	Effect of prostaglandins A-1, E-2 and F-2α on spermatogenesis in rats 1980 ·Reproduction ·(unknown), D. Roychowdhury	9
15	Effect of Aspirin on Spermatogenesis in Mature and Immature Rats 1980 ·International Journal of Andrology ·(unknown), Pragnesh Patel, D. Roychowdhury	25
16	Effects of Aspirin on Blood Plasma Levels of Testosterone, LH and FSH in Maturing Male Rats 1980 ·International Journal of Andrology ·(unknown), Anagha Gurjar, (unknown), A. R. Sheth, D. Roychowdhury	20
17	Effect of unilateral visual deprivation on the activities of acetylcholinesterase, cholinesterase and carbonic anhydrase of the optic lobe of pigeon 1974 ·Journal of Neurochemistry ·Tapan Chakrabarti, (unknown), D. Roychowdhury, Hatim F. Daginawala	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact